Event Details

As the health care market for AI is increasing at a rate of 40% and is expected to reach $6.6 billion by 2021, experts predict AI to have a significant impact in diverse areas of health care such as chronic disease management and clinical decision making. Some imminent challenges must be overcome before physicians and other healthcare professionals can fully benefit from a digitized health ecosystem. Regulatory bodies have to re-imagine their approaches to AI regulations to fit the rapid, iterative nature of AI-based solutions. The APACMed Webinar on the theme – Regulatory Advances in Artificial Intelligence/ Machine Learning, will provide all the novel details on the same and the best approach, going ahead.


Key Discussion Points

  • Snapshot of AI regulations US, EU & Asia Pacific
  • Overview of types of AI
  • Navigating the AI-SaMD Regulatory Landscape
  • Best Practices in Development and Validation
  • Regulatory Pathways for Modifications

Feb 10, 2021

7 PM - 8:30 PM (GMT+8)

Speakers

  • Varun Veigas (Regional Regulatory Affairs and Policy Lead, Asia Pacific at Roche Diagnostics)

    Varun Veigas

    Regional Regulatory Affairs and Policy Lead, Asia Pacific at Roche Diagnostics

    Read Bio
  • Manan Hathi (Senior Manager of Regulatory Affairs Software at Stryker)

    Manan Hathi

    Senior Manager of Regulatory Affairs Software at Stryker

    Read Bio
  • Anirudh Sen (Moderator) (Country Lead (India) at APACMed)

    Anirudh Sen (Moderator)

    Country Lead (India) at APACMed

    Read Bio
Menu